Literature DB >> 33594790

Effectiveness of Secukinumab in the treatment of moderate-severe hidradenitis suppurativa: results from an Italian multicentric retrospective study in a real-life setting.

S Ribero1, A Ramondetta1, G Fabbrocini2, V Bettoli3, C Potenza4, A Chiricozzi5,6, M Licciardello1, A V Marzano7,8, L Bianchi9, G Rozzo1, L Fania10, C Marasca2, G Odorici3, A Mambrin4, C Moltrasio7,11, R D Caposiena Caro9, N Skroza4, P Quaglino1, N Siliquini1, P Dapavo1.   

Abstract

Entities:  

Year:  2021        PMID: 33594790     DOI: 10.1111/jdv.17178

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  4 in total

1.  Interleukin-17RA blockade by brodalumab decreases inflammatory pathways in hidradenitis suppurativa skin and serum.

Authors:  Kristina Navrazhina; John W Frew; David Grand; Samuel C Williams; Hong Hur; Juana Gonzalez; Sandra Garcet; James G Krueger
Journal:  Br J Dermatol       Date:  2022-06-02       Impact factor: 11.113

Review 2.  New and Emerging Targeted Therapies for Hidradenitis Suppurativa.

Authors:  Adela Markota Čagalj; Branka Marinović; Zrinka Bukvić Mokos
Journal:  Int J Mol Sci       Date:  2022-03-29       Impact factor: 5.923

3.  Similar Levels of Efficacy of Two Different Maintenance Doses of Adalimumab on Clinical Severity and Quality of Life of Patients with Hidradenitis Suppurativa.

Authors:  Luca Fania; Giulia Giovanardi; Tonia Samela; Dante Caposiena; Andrea Chiricozzi; Flaminia Antonelli; Pierluigi Saraceni; Fulvia Elia; Simone Garcovich; Davide Ciccone; Maria Vittoria Cannizzaro; Emanuele Miraglia; Chiara Iacovino; Sandra Giustini; Nevena Skroza; Alessandra Mambrin; Concetta Potenza; Luca Bianchi; Ketty Peris; Damiano Abeni
Journal:  J Clin Med       Date:  2022-07-12       Impact factor: 4.964

4.  The inflammatory proteome of hidradenitis suppurativa skin is more expansive than that of psoriasis vulgaris.

Authors:  Kristina Navrazhina; Sandra Garcet; John W Frew; Xiuzhong Zheng; Israel Coats; Emma Guttman-Yassky; James G Krueger
Journal:  J Am Acad Dermatol       Date:  2021-07-30       Impact factor: 11.527

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.